1. Home
  2. FSI vs ACRV Comparison

FSI vs ACRV Comparison

Compare FSI & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

N/A

Current Price

$6.18

Market Cap

63.7M

ML Signal

N/A

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

N/A

Current Price

$1.91

Market Cap

74.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSI
ACRV
Founded
1991
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.7M
74.0M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
FSI
ACRV
Price
$6.18
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $11.50
AVG Volume (30 Days)
10.4K
★ 326.7K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
★ 1.65%
N/A
EPS Growth
N/A
★ 15.13
EPS
★ N/A
N/A
Revenue
★ $15,494,325.00
N/A
Revenue This Year
$24.09
N/A
Revenue Next Year
$60.56
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.85
$1.27
52 Week High
$9.89
$3.56

Technical Indicators

Market Signals
Indicator
FSI
ACRV
Relative Strength Index (RSI) 61.48 46.59
Support Level $5.95 $1.61
Resistance Level $6.67 $2.21
Average True Range (ATR) 0.17 0.12
MACD 0.02 -0.02
Stochastic Oscillator 53.75 30.43

Price Performance

Historical Comparison
FSI
ACRV

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

Share on Social Networks: